PMID- 34485470 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220426 IS - 2313-1810 (Electronic) IS - 2312-0053 (Print) IS - 2312-0053 (Linking) VI - 35 IP - 1 DP - 2020 TI - Multilocus sequence typing of azole-resistant Candida auris strains, South Africa. PG - 116 LID - 10.4102/sajid.v35i1.116 [doi] LID - 116 AB - BACKGROUND: Candida auris is an emerging multidrug-resistant fungal pathogen associated with high mortality. METHODS: We investigated the genetic relatedness of clinical C. auris isolates from patients admitted to either public- or private-sector hospitals, which were submitted to a reference laboratory from 2012 to 2015. Patient demographics and clinical details were recorded. We performed antifungal susceptibility testing, sequencing of the hotspot 1 and 2 regions of the FKS1 and FKS2 genes for all isolates with an echinocandin minimum inhibitory concentration (MIC) of >/=1 microg/mL and cluster analysis using multilocus sequence typing. RESULTS: Eighty-five isolates were confirmed as C. auris. The median patient age was 59 years [inter-quartile range (IQR): 48-68 years], with male patients accounting for 68% of cases. Specimen types included urine (29%), blood (27%), central venous catheter tips (25%), irrigation fluid (7%), tissue (5%), respiratory tract specimens (4%) and other (3%). Ninety-seven per cent of isolates were resistant to fluconazole, 7% were resistant to both fluconazole and voriconazole, 8% were resistant to both fluconazole and echinocandins (considered multidrug resistant) and all were susceptible to amphotericin B. Of the 15 randomly selected fluconazole-resistant isolates, 14 isolates had an isavuconazole MIC